← Back to Search

Dietary Supplement

Muscadine Grape Extract for Fatigue

Phase < 1
Recruiting
Led By Heidi Klepin, MD, MS
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Eligible hematologic malignancies include lymphoma any subtype any stage in remission, multiple myeloma in remission, leukemia any subtype in remission.
Age 65 years and older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Study Summary

This trial is testing if a grape supplement can help reduce fatigue in cancer patients over 70.

Who is the study for?
This trial is for people aged 70 or older who have been treated for certain types of cancer, are in remission, and suffer from fatigue. They must be able to walk (with aids like canes if needed), have normal organ function, not require oxygen for lung disease, and not be on treatments like Coumadin or Warfarin.Check my eligibility
What is being tested?
Researchers are testing whether muscadine grape extract can help improve fatigue in elderly individuals with a history of treated cancer. Participants will either receive the grape extract or a placebo and provide feedback through questionnaires assessing their quality of life.See study design
What are the potential side effects?
Potential side effects aren't specified but could include allergic reactions to muscadine grapes for those sensitive to them. As it's a natural extract being tested against a placebo, other side effects may be minimal.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My blood cancer (like lymphoma, leukemia, or multiple myeloma) is currently in remission.
Select...
I am 65 years old or older.
Select...
I have felt fatigued to a significant degree in the past week.
Select...
I can walk by myself, but I may use a cane or walker.
Select...
My kidneys are functioning well enough (creatinine clearance over 30 mL/min).

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient Reported Outcomes Measurement System (PROMIS) Fatigue 7a Questionnaire
Secondary outcome measures
6-Minute Walk Test
Adherence - Pill Count
Fried Frailty Index
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Muscadine Grape Extract ArmExperimental Treatment4 Interventions
Muscadine grape extract pill (12 week supply)
Group II: Placebo ArmPlacebo Group4 Interventions
Placebo provided (12 week supply)

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,242 Previous Clinical Trials
1,004,203 Total Patients Enrolled
15 Trials studying Fatigue
2,224 Patients Enrolled for Fatigue
Heidi Klepin, MD, MSPrincipal InvestigatorWake Forest University Health Sciences
1 Previous Clinical Trials
25 Total Patients Enrolled

Media Library

Muscadine grape extract (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT04495751 — Phase < 1
Fatigue Research Study Groups: Placebo Arm, Muscadine Grape Extract Arm
Fatigue Clinical Trial 2023: Muscadine grape extract Highlights & Side Effects. Trial Name: NCT04495751 — Phase < 1
Muscadine grape extract (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04495751 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby Aug 2024